Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Julphar
Fuji
Chubb
Harvard Business School
Daiichi Sankyo
Express Scripts
Johnson and Johnson
Chinese Patent Office

Generated: June 19, 2018

DrugPatentWatch Database Preview

RYTHMOL SR Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Rythmol Sr patents expire, and what generic alternatives are available?

Rythmol Sr is a drug marketed by Glaxosmithkline Llc and is included in one NDA.

The generic ingredient in RYTHMOL SR is propafenone hydrochloride. There are eleven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the propafenone hydrochloride profile page.
Drug patent expirations by year for RYTHMOL SR
Pharmacology for RYTHMOL SR
Drug ClassAntiarrhythmic
Medical Subject Heading (MeSH) Categories for RYTHMOL SR
Synonyms for RYTHMOL SR
1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenylpropan-1-one hydrochloride
1-(2-[2-Hydroxy-3-(propylamino)propoxy]phenyl)-3-phenyl-1propanone
1-[2-(2-Hydroxy-3-(propylamino)propoxy)phenyl]-3-phenyl-1-propanone hydrochloride
1-[2-[2-hydroxy-3- propoxy]phenyl]-3-phenylpropan-1-onehydrochloride
1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-1-propanone hydrochloride
1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one hydrochloride
1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one hydrochloride
1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one;hydrochloride
1-[2-[2-oxidanyl-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one hydrochloride
1-{2-[2-hydroxy-3-(propylamino)propoxy]phenyl}-3-phenylpropan-1-one hydrochloride
1-Propanone, 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-, hydrochloride
1-Propanone,1-[2-[(2R)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-, hydrochloride(9CI)
1-Propanone,1-[2-[(2S)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-, hydrochloride(1:1)
163858-56-8
183P227
2-hydroxy-3-[2-(3-phenylpropanoyl)phenoxy]-N-propylpropan-1-aminium chloride
2'-(2-Hydroxy-3-(propylamino)propoxy)-3-phenylpropiophenone hydrochloride
2'-(2-hydroxy-3-propylaminopropoxy)-3-phenylpropiophenone hydrochloride
2'-[2-Hydroxy-3-(propylamino)propoxy]-3-phenylpropiophenone Hydrochloride
34183-22-7
54063-53-5 (Parent)
A822113
AB0011670
AC-11360
AC1L1W9R
AC1Q39QV
AC1Q3DVX
ACMC-20cvw7
ACMC-20cvw9
AKOS008901409
AN-6428
Arythmol
Baxarytmon
C21H28ClNO3
CCG-39061
CHEBI:8466
CHEMBL1201063
CPD000058493
CS-2538
CTK6E5427
D00640
EINECS 251-867-9
EN300-51034
EU-0100919
Fenoprain
FT-0630579
HMS1569D19
HMS1922M16
HY-B0432A
J-019481
J10361
K-7828
KS-000000SR
KS-5030
LP00919
LS-125353
MCULE-5193630487
MFCD00079243
MLS000069682
MLS001148185
MLS002222267
MolPort-003-666-514
NCGC00094230-01
NCGC00094230-02
NCGC00094230-03
NCGC00094230-04
NCGC00094230-05
NCGC00261604-01
NSC-758640
NSC758640
Opera_ID_1835
P 4670
P2301
Pharmakon1600-01503935
Prestwick_831
Pronon
Propafenon hydrochlorid
Propafenon hydrochlorid [German]
Propafenone (hydrochloride)
Propafenone HCl
PROPAFENONE HYDROCHLORIDE
Propafenone hydrochloride (JP17/USP)
Propafenone hydrochloride [USAN:JAN]
Propafenone hydrochloride, European Pharmacopoeia (EP) Reference Standard
Propafenone hydrochloride, United States Pharmacopeia (USP) Reference Standard
Propiophenone, 2'-(2-hydroxy-3-(propylamino)propoxy)-3-phenyl-, hydrochloride
Rhythmonorm
Rythmol (TN)
Rytmonorm
SA 79
SAM002548929
SC-47004
SCHEMBL41412
SMR000058493
SPECTRUM1503935
SR-01000000192
SR-01000000192-2
ST51054219
Tox21_500919
WZ 884
XWIHRGFIPXWGEF-UHFFFAOYSA-N
Z802671518

US Patents and Regulatory Information for RYTHMOL SR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline Llc RYTHMOL SR propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021416-001 Sep 4, 2003 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc RYTHMOL SR propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021416-002 Sep 4, 2003 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc RYTHMOL SR propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021416-003 Sep 4, 2003 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for RYTHMOL SR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc RYTHMOL SR propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021416-001 Sep 4, 2003 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc RYTHMOL SR propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021416-003 Sep 4, 2003 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc RYTHMOL SR propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021416-002 Sep 4, 2003 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for RYTHMOL SR
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Extended-release Capsules 325 mg ➤ Subscribe 2006-11-07
➤ Subscribe Extended-release Capsules 225 mg and 425 mg ➤ Subscribe 2006-10-11

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Queensland Health
Harvard Business School
Johnson and Johnson
AstraZeneca
McKinsey
Medtronic
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.